메뉴 건너뛰기




Volumn 34, Issue 2, 2011, Pages 314-319

Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; METFORMIN; PIOGLITAZONE; SITAGLIPTIN;

EID: 79951689950     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1119     Document Type: Article
Times cited : (54)

References (25)
  • 1
    • 64749100501 scopus 로고    scopus 로고
    • Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • American Diabetes Association; European Association for Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
    • (2009) Diabetes Care , vol.32 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 2
    • 34247131681 scopus 로고    scopus 로고
    • The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys
    • DOI 10.1111/j.1742-1241.2007.01336.x
    • Bays HE, Chapman RH, Grandy S; SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61:737-747 (Pubitemid 46587875)
    • (2007) International Journal of Clinical Practice , vol.61 , Issue.5 , pp. 737-747
    • Bays, H.E.1    Chapman, R.H.2    Grandy, S.3
  • 3
    • 0030778116 scopus 로고    scopus 로고
    • The prevention and treatment of obesity. Application to type 2 diabetes
    • Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity. Application to type 2 diabetes. Diabetes Care 1997;20: 1744-1766
    • (1997) Diabetes Care , vol.20 , pp. 1744-1766
    • Maggio, C.A.1    Pi-Sunyer, F.X.2
  • 4
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 5
    • 17744395778 scopus 로고    scopus 로고
    • Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance
    • Charpentier G, Fleury F, Dubroca I, Vaur L, Clerson P. Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance. Diabetes Metab 2005;31: 189-195 (Pubitemid 40577203)
    • (2005) Diabetes and Metabolism , vol.31 , Issue.2 , pp. 189-195
    • Charpentier, G.1    Fleury, F.2    Dubroca, I.3    Vaur, L.4    Clerson, P.5
  • 6
    • 0000078123 scopus 로고    scopus 로고
    • Recommendations for evaluating the validity of quality of life claims for labeling and promotion
    • Leidy NK, Revicki DA, Genesté B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113-127
    • (1999) Value Health , vol.2 , pp. 113-127
    • Leidy, N.K.1    Revicki, D.A.2    Genesté, B.3
  • 8
    • 14244255984 scopus 로고    scopus 로고
    • The DIAB.&TE.S Project: How patients perceive diabetes and diabetes therapy
    • DIAB. & TE.S Project Study Group
    • Marra G; DIAB. & TE.S Project Study Group. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy. Acta Biomed 2004;75:164-170
    • (2004) Acta Biomed , vol.75 , pp. 164-170
    • Marra, G.1
  • 9
    • 67649774247 scopus 로고    scopus 로고
    • Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily
    • Best JH, Boye KS, Rubin RR, Cao D, Kim TH, Peyrot M. Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily. Diabet Med 2009;26:722-728
    • (2009) Diabet Med , vol.26 , pp. 722-728
    • Best, J.H.1    Boye, K.S.2    Rubin, R.R.3    Cao, D.4    Kim, T.H.5    Peyrot, M.6
  • 11
    • 1242283924 scopus 로고    scopus 로고
    • Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: A prospective, randomized trial
    • DOI 10.1016/j.amjmed.2003.07.023
    • Aljabri K, Kozak SE, Thompson DM. Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. Am J Med 2004;116: 230-235 (Pubitemid 38224230)
    • (2004) American Journal of Medicine , vol.116 , Issue.4 , pp. 230-235
    • Aljabri, K.1    Kozak, S.E.2    Thompson, D.M.3
  • 12
    • 33645988220 scopus 로고    scopus 로고
    • Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): The Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study
    • RESULT Study Group
    • Rosenstock J, Goldstein BJ, Vinik AI, et al.; RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Diabetes Obes Metab 2006;8:49-57
    • (2006) Diabetes Obes Metab , vol.8 , pp. 49-57
    • Rosenstock, J.1    Goldstein, B.J.2    Vinik, A.I.3
  • 13
    • 28444440888 scopus 로고    scopus 로고
    • Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week,multicenter, randomized, double-blind, parallel-group study
    • Bailey CJ, Bagdonas A, Rubes J, et al. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week,multicenter, randomized, double-blind, parallel-group study.Clin Ther 2005; 27:1548-1561
    • (2005) Clin Ther , vol.27 , pp. 1548-1561
    • Bailey, C.J.1    Bagdonas, A.2    Rubes, J.3
  • 14
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Action to Control Cardiovascular Risk in Diabetes Study Group
    • Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
    • Gerstein, H.C.1    Miller, M.E.2    Byington, R.P.3
  • 15
    • 0031578033 scopus 로고    scopus 로고
    • World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects
    • World Medical Association Declaration of Helsinki
    • World Medical Association Declaration of Helsinki. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277:925-926
    • (1997) JAMA , vol.277 , pp. 925-926
  • 16
    • 77955573674 scopus 로고    scopus 로고
    • A comparison of the efficacy and safety of exenatide once weekly, sitagliptin, and pioglitazone when added to metformin in the treatment of type 2 diabetes. DURATION-2: A randomized trial
    • for the DURATION-2 Study Group
    • Bergenstal RM. Wysham, MacConell L, Malloy J, Yan P, Wilhelm K, Malone J, Porter LE, for the DURATION-2 Study Group: A comparison of the efficacy and safety of exenatide once weekly, sitagliptin, and pioglitazone when added to metformin in the treatment of type 2 diabetes. DURATION-2: a randomized trial. Lancet 2010;376:431-439
    • (2010) Lancet , vol.376 , pp. 431-439
    • Bergenstal, R.M.1    Wysham MacConell, L.2    Malloy, J.3    Yan, P.4    Wilhelm, K.5    Malone, J.6    Porter, L.E.7
  • 17
    • 0042388520 scopus 로고    scopus 로고
    • Assessing weight-related quality of life in obese persons with type 2 diabetes
    • DOI 10.1016/S0168-8227(03)00113-X
    • Kolotkin RL, Crosby RD, Williams GR. Assessing weight-related quality of life in obese persons with type 2 diabetes. Diabetes Res Clin Pract 2003;61:125-132 (Pubitemid 37013657)
    • (2003) Diabetes Research and Clinical Practice , vol.61 , Issue.2 , pp. 125-132
    • Kolotkin, R.L.1    Crosby, R.D.2    Williams, G.R.3
  • 18
    • 0036071652 scopus 로고    scopus 로고
    • Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
    • DOI 10.1177/027298902400448902
    • Clarke P, Gray A, Holman R. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62). Med Decis Making 2002;22:340-349 (Pubitemid 34791321)
    • (2002) Medical Decision Making , vol.22 , Issue.4 , pp. 340-349
    • Clarke, P.1    Gray, A.2    Holman, R.3
  • 19
    • 35649023181 scopus 로고    scopus 로고
    • Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
    • Matza LS, Boye KS, Yurgin N. Validation of two generic patient-reported outcome measures in patients with type 2 diabetes. Health Qual Life Outcomes 2007;5:47
    • (2007) Health Qual Life Outcomes , vol.5 , pp. 47
    • Matza, L.S.1    Boye, K.S.2    Yurgin, N.3
  • 22
    • 68149116304 scopus 로고    scopus 로고
    • How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference
    • Peyrot M, Rubin RR. How does treatment satisfaction work? Modeling determinants of treatment satisfaction and preference. Diabetes Care 2009;32:1411-1417
    • (2009) Diabetes Care , vol.32 , pp. 1411-1417
    • Peyrot, M.1    Rubin, R.R.2
  • 23
    • 77956707365 scopus 로고    scopus 로고
    • Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin
    • Hermansen K, Kolotkin RL, Hammer M, Zdravkovic M, Matthews D. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin. Prim Care Diabetes 2010;4:113-117
    • (2010) Prim Care Diabetes , vol.4 , pp. 113-117
    • Hermansen, K.1    Kolotkin, R.L.2    Hammer, M.3    Zdravkovic, M.4    Matthews, D.5
  • 24
    • 74849099588 scopus 로고    scopus 로고
    • Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
    • Pollack MF, Purayidathil FW, Bolge SC, Williams SA. Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract 2010;87: 204-210
    • (2010) Diabetes Res Clin Pract , vol.87 , pp. 204-210
    • Pollack, M.F.1    Purayidathil, F.W.2    Bolge, S.C.3    Williams, S.A.4
  • 25
    • 65649111800 scopus 로고    scopus 로고
    • Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications
    • Bharmal M, Payne K, Atkinson MJ, Desrosiers M-P, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications. Health Qual Life Outcomes 2009;7:36
    • (2009) Health Qual Life Outcomes , vol.7 , pp. 36
    • Bharmal, M.1    Payne, K.2    Atkinson, M.J.3    Desrosiers, M.-P.4    Morisky, D.E.5    Gemmen, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.